Header Logo

Connection

Mayer Davidson to Diabetes Mellitus, Type 2

Back to Details
This is a "connection" page, showing publications Mayer Davidson has written about Diabetes Mellitus, Type 2.
Mayer Davidson
Connection Strength
19.944
Diabetes Mellitus, Type 2
  1. Glycaemic treatment of newly diagnosed type 2 diabetes. Diabetes Obes Metab. 2024 Nov; 26(11):5492-5493.
    View in: PubMed
    Score: 0.709
  2. In adults with BMI =27 kg/m2 and type 2 diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk. Ann Intern Med. 2023 11; 176(11):JC129.
    View in: PubMed
    Score: 0.670
  3. Review of Prediabetes. JAMA. 2023 08 08; 330(6):564.
    View in: PubMed
    Score: 0.659
  4. In adults with obesity without diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk. Ann Intern Med. 2022 10; 175(10):JC116.
    View in: PubMed
    Score: 0.621
  5. Comment on Aleppo et al. The Effect of Discontinuing Continuous Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin. Diabetes Care 2021;44:2729-2737. Diabetes Care. 2022 04 01; 45(4):e84.
    View in: PubMed
    Score: 0.600
  6. Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) Study. Diabetes Care 2020;43:2916-2922. Diabetes Care. 2021 05; 44(5):e105.
    View in: PubMed
    Score: 0.563
  7. Metformin Should Not Be Used to Treat Prediabetes. Diabetes Care. 2020 09; 43(9):1983-1987.
    View in: PubMed
    Score: 0.537
  8. Second-generation basal insulins to initiate insulin therapy in type 2 diabetes: A need for clinical evidence before incurring increased costs. Diabetes Obes Metab. 2020 05; 22(5):719-721.
    View in: PubMed
    Score: 0.520
  9. SGLT-2 inhibitors were not linked to severe or nonsevere UTIs vs DPP-4 inhibitors or GLP-1 agonists. Ann Intern Med. 2019 12 17; 171(12):JC70.
    View in: PubMed
    Score: 0.512
  10. Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot study. J Diabetes. 2020 Jan; 12(1):91-94.
    View in: PubMed
    Score: 0.506
  11. The Case for Using Human Insulin. Am J Med. 2020 02; 133(2):e23-e24.
    View in: PubMed
    Score: 0.496
  12. Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes. Ann Intern Med. 2019 04 16; 170(8):JC39.
    View in: PubMed
    Score: 0.488
  13. Delayed response to an injection of U-500 regular insulin is not rare. J Diabetes. 2019 Jul; 11(7):519-521.
    View in: PubMed
    Score: 0.487
  14. Effectiveness of certified diabetes educators following pre-approved protocols to redesign diabetes care delivery in primary care: Results of the REMEDIES 4D trial. Contemp Clin Trials. 2018 01; 64:201-209.
    View in: PubMed
    Score: 0.439
  15. Diabetic retinopathy is not present in newly diagnosed diabetic patients. Diabetologia. 2016 12; 59(12):2727.
    View in: PubMed
    Score: 0.411
  16. Response to comment on Kahn and Davidson. The reality of type 2 diabetes prevention. Diabetes Care 2014;37:943-949. Diabetes Care. 2014 Dec; 37(12):e276-7.
    View in: PubMed
    Score: 0.361
  17. Response to comment on Kahn and Davidson. The reality of type 2 diabetes prevention. Diabetes care 2014;37:943-949. Diabetes Care. 2014 Aug; 37(8):e187.
    View in: PubMed
    Score: 0.352
  18. Rationale, design, and implementation of a cluster randomized trial using certified diabetes educators to intensify treatment for glycemia, blood pressure and lipid control: REMEDIES 4D. Contemp Clin Trials. 2014 Sep; 39(1):124-31.
    View in: PubMed
    Score: 0.351
  19. The reality of type 2 diabetes prevention. Diabetes Care. 2014 Apr; 37(4):943-9.
    View in: PubMed
    Score: 0.344
  20. Self-mixed/split insulin regimen: a serious omission in the ADA/EASD position statement. Diabetes Care. 2014; 37(1):3-4.
    View in: PubMed
    Score: 0.339
  21. Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos. Ethn Dis. 2014; 24(2):195-9.
    View in: PubMed
    Score: 0.339
  22. Comment on: Hellemons et al. Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial. Diabetes Care 2011;34:2078-2083. Diabetes Care. 2011 Dec; 34(12):e188.
    View in: PubMed
    Score: 0.293
  23. Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitus. Endocr Pract. 2011 Sep-Oct; 17(5):691-8.
    View in: PubMed
    Score: 0.288
  24. A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure. Endocr Pract. 2011 May-Jun; 17(3):395-403.
    View in: PubMed
    Score: 0.281
  25. Evaluation of self monitoring of blood glucose in non-insulin-treated diabetic patients by randomized controlled trials: little bang for the buck. Rev Recent Clin Trials. 2010 Sep; 5(3):138-42.
    View in: PubMed
    Score: 0.269
  26. Integrating nurse-directed diabetes management into a primary care setting. Am J Manag Care. 2010 Sep; 16(9):652-6.
    View in: PubMed
    Score: 0.269
  27. U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care. 2010 Feb; 33(2):281-3.
    View in: PubMed
    Score: 0.254
  28. Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation. Curr Opin Endocrinol Diabetes Obes. 2009 Apr; 16(2):107-12.
    View in: PubMed
    Score: 0.244
  29. No need for the needle (at first). Diabetes Care. 2008 Oct; 31(10):2070-1.
    View in: PubMed
    Score: 0.235
  30. The relationship of glycaemic control and triglycerides in patients with diabetes mellitus: a PreCIS Database Study. Diabetes Obes Metab. 2009 Feb; 11(2):118-22.
    View in: PubMed
    Score: 0.230
  31. Clinical implications of the DREAM Study. Diabetes Care. 2007 Feb; 30(2):418-20.
    View in: PubMed
    Score: 0.210
  32. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Diabetes Care. 2006 Nov; 29(11):2504-5.
    View in: PubMed
    Score: 0.206
  33. Does the metabolic syndrome exist: response to Grundy. Diabetes Care. 2006 Nov; 29(11):2565; author reply 2565-6.
    View in: PubMed
    Score: 0.206
  34. Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes. Diabetes Care. 2006 Jun; 29(6):1395-6.
    View in: PubMed
    Score: 0.200
  35. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al. Diabetes Care. 2005 Oct; 28(10):2597; author reply 2597-8.
    View in: PubMed
    Score: 0.191
  36. Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005 Jun; 28(6):1531-3.
    View in: PubMed
    Score: 0.187
  37. SF-36 and diabetes outcome measures. Diabetes Care. 2005 Jun; 28(6):1536-7.
    View in: PubMed
    Score: 0.187
  38. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005 Apr; 118(4):422-5.
    View in: PubMed
    Score: 0.185
  39. Starting insulin therapy in type 2 diabetic patients: does it really matter how? Diabetes Care. 2005 Feb; 28(2):494-5.
    View in: PubMed
    Score: 0.183
  40. Thiazolidinediones. N Engl J Med. 2005 Jan 13; 352(2):205-7; author reply 205-7.
    View in: PubMed
    Score: 0.182
  41. Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care. 2005 Jan; 28(1):222-4.
    View in: PubMed
    Score: 0.181
  42. Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism. 2004 Sep; 53(9):1166-73.
    View in: PubMed
    Score: 0.177
  43. Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population. Diabetes Care. 2004 Jul; 27(7):1741-2.
    View in: PubMed
    Score: 0.175
  44. Triple therapy: definitions, application, and treating to target. Diabetes Care. 2004 Jul; 27(7):1834-5.
    View in: PubMed
    Score: 0.175
  45. Twice-Daily NPH or mixture insulins versus triple therapy: apples versus oranges: response to Poulsen et al. Diabetes Care. 2004 Jul; 27(7):1846; author reply 1847-8.
    View in: PubMed
    Score: 0.175
  46. Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians. Diabetes Obes Metab. 2024 Aug; 26(8):3475-3477.
    View in: PubMed
    Score: 0.175
  47. Status of research funding by the American Diabetes Association--5th and final year. Diabetes Care. 2004 May; 27(5):1235.
    View in: PubMed
    Score: 0.173
  48. Metabolic syndrome/insulin resistance syndrome/pre-diabetes: new section in diabetes care. Diabetes Care. 2003 Nov; 26(11):3179.
    View in: PubMed
    Score: 0.167
  49. Is treatment of insulin resistance beneficial independent of glycemia? Diabetes Care. 2003 Nov; 26(11):3184-6.
    View in: PubMed
    Score: 0.167
  50. Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003 Aug; 26(8):2281-7.
    View in: PubMed
    Score: 0.164
  51. Tests of glycemia. Ann Intern Med. 2003 Mar 18; 138(6):517; author reply 517.
    View in: PubMed
    Score: 0.160
  52. Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients. A pilot study. J Diabetes Complications. 2002 Nov-Dec; 16(6):377-81.
    View in: PubMed
    Score: 0.156
  53. Treatment decisions for type 2 diabetes. JAMA. 2002 Apr 03; 287(13):1646-7; author reply 1647-8.
    View in: PubMed
    Score: 0.150
  54. HbA(1c) measurements do not improve the detection of type 2 diabetes in a randomly selected population. Diabetes Care. 2001 Nov; 24(11):2017-8.
    View in: PubMed
    Score: 0.146
  55. Effect of data management on a central server on HbA1c levels in insulin-requiring patients. Diabetes Care. 2000 May; 23(5):706-7.
    View in: PubMed
    Score: 0.131
  56. Glycosylated hemoglobin as a diagnostic test for type 2 diabetes mellitus. JAMA. 2000 Feb 02; 283(5):606-7.
    View in: PubMed
    Score: 0.129
  57. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA. 1999 Apr 07; 281(13):1203-10.
    View in: PubMed
    Score: 0.122
  58. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections. JAMA. 2017 01 24; 317(4):363-364.
    View in: PubMed
    Score: 0.105
  59. Treatment of non-insulin-dependent diabetes mellitus. Mayo Clin Proc. 1997 Jan; 72(1):92.
    View in: PubMed
    Score: 0.104
  60. An overview of metformin in the treatment of type 2 diabetes mellitus. Am J Med. 1997 Jan; 102(1):99-110.
    View in: PubMed
    Score: 0.104
  61. Maximal dose glyburide therapy in markedly symptomatic patients with type 2 diabetes: a new use for an old friend. J Clin Endocrinol Metab. 1996 Jul; 81(7):2423-7.
    View in: PubMed
    Score: 0.101
  62. A Reappraisal of Prediabetes. J Clin Endocrinol Metab. 2016 07; 101(7):2628-35.
    View in: PubMed
    Score: 0.101
  63. Quality of outpatient care provided to diabetic patients. A health maintenance organization experience. Diabetes Care. 1996 Jun; 19(6):601-6.
    View in: PubMed
    Score: 0.100
  64. Pioglitazone (Actos) and bladder cancer: Legal system triumphs over the evidence. J Diabetes Complications. 2016 08; 30(6):981-5.
    View in: PubMed
    Score: 0.099
  65. Response to Nathan. Diabetes Care. 1995 Sep; 18(9):1306-8.
    View in: PubMed
    Score: 0.095
  66. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014 Oct; 99(10):3551-60.
    View in: PubMed
    Score: 0.088
  67. The influence of diabetes mellitus on the risk of abdominal aortic surgery. Am Surg. 1994 Jun; 60(6):436-40.
    View in: PubMed
    Score: 0.087
  68. Treatment of poorly controlled type 2 diabetes. Compr Ther. 1994; 20(6):321-5.
    View in: PubMed
    Score: 0.085
  69. Role of glucose transport and GLUT4 transporter protein in type 2 diabetes mellitus. J Clin Endocrinol Metab. 1993 Jul; 77(1):25-6.
    View in: PubMed
    Score: 0.082
  70. Successful treatment of markedly symptomatic patients with type II diabetes mellitus using high doses of sulfonylurea agents. West J Med. 1992 Aug; 157(2):199-200.
    View in: PubMed
    Score: 0.077
  71. Rational use of sulfonylureas. Postgrad Med. 1992 Aug; 92(2):69-70, 73-6, 79-85.
    View in: PubMed
    Score: 0.077
  72. [Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes]. Nihon Rinsho. 2012 May; 70 Suppl 3:591-601.
    View in: PubMed
    Score: 0.075
  73. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012 Feb 27; 344:e486.
    View in: PubMed
    Score: 0.074
  74. Insulin plus a sulfonylurea agent for treating type 2 diabetes. Ann Intern Med. 1991 Jul 01; 115(1):45-53.
    View in: PubMed
    Score: 0.071
  75. Use of sulfonylurea agents in older diabetic patients. Clin Geriatr Med. 1990 Nov; 6(4):903-21.
    View in: PubMed
    Score: 0.068
  76. Individual patient data meta-analysis of trials of self-monitoring of blood glucose in non-insulin treated type 2 diabetes: protocol for a systematic review. Prim Care Diabetes. 2009 May; 3(2):117-21.
    View in: PubMed
    Score: 0.061
  77. How our current medical care system fails people with diabetes: lack of timely, appropriate clinical decisions. Diabetes Care. 2009 Feb; 32(2):370-2.
    View in: PubMed
    Score: 0.060
  78. Screening for diabetes mellitus. Ann Intern Med. 1989 Jan 15; 110(2):168.
    View in: PubMed
    Score: 0.060
  79. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2009 Jan; 52(1):17-30.
    View in: PubMed
    Score: 0.059
  80. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009 Jan; 32(1):193-203.
    View in: PubMed
    Score: 0.059
  81. Use oral hypoglycemics with caution...but keep caution in context. Geriatrics. 1988 Aug; 43(8):83-4.
    View in: PubMed
    Score: 0.058
  82. Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy. Update regarding the thiazolidinediones. Diabetologia. 2008 Jan; 51(1):8-11.
    View in: PubMed
    Score: 0.056
  83. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2008 Jan; 31(1):173-5.
    View in: PubMed
    Score: 0.056
  84. The dilemma of self-monitoring of blood glucose. Diabetologia. 2007 Mar; 50(3):497-9.
    View in: PubMed
    Score: 0.053
  85. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007 Mar; 30(3):753-9.
    View in: PubMed
    Score: 0.053
  86. Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population. Diabetes Care. 2007 Feb; 30(2):224-7.
    View in: PubMed
    Score: 0.052
  87. Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2006 Aug; 49(8):1711-21.
    View in: PubMed
    Score: 0.051
  88. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006 Aug; 29(8):1963-72.
    View in: PubMed
    Score: 0.051
  89. Pathogenesis of type 2 diabetes mellitus: an interpretation of current data. Am J Med Sci. 1986 Jul; 292(1):35-9.
    View in: PubMed
    Score: 0.050
  90. Exenatide. Nat Rev Drug Discov. 2005 Sep; 4(9):713-4.
    View in: PubMed
    Score: 0.048
  91. Pathogenesis of impaired glucose tolerance and type II diabetes mellitus--current status. West J Med. 1985 Feb; 142(2):219-29.
    View in: PubMed
    Score: 0.046
  92. More evidence to support "outsourcing" of diabetes care. Diabetes Care. 2004 Apr; 27(4):995.
    View in: PubMed
    Score: 0.043
  93. Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. Diabetes Care. 2003 Jun; 26(6):1796-801.
    View in: PubMed
    Score: 0.041
  94. Controlling blood glucose levels in patients with type 2 diabetes mellitus. An evidence-based policy statement by the American Academy of Family Physicians and American Diabetes Association. J Fam Pract. 2000 May; 49(5):453-60.
    View in: PubMed
    Score: 0.033
  95. Inhibition of sleep-induced growth hormone secretion: no effect on diabetic control. Diabetes Care. 1990 Jul; 13(7):813-4.
    View in: PubMed
    Score: 0.017
  96. Exogenous insulin therapy slows weight loss in type 2 diabetic patients. Int J Obes. 1988; 12(2):149-55.
    View in: PubMed
    Score: 0.014
  97. Cost-effective screening for diabetic retinopathy using a nonmydriatic retinal camera in a prepaid health-care setting. Diabetes Care. 1993 Aug; 16(8):1193-5.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.